DE1195306B - Process for the preparation of a 3-methyl-7-keto-8- (3'-ketobutyl) -3, 4- [3'-acyloxy-cyclo-pentano- (2 ', 1')] decahydronaphthalene compound - Google Patents

Process for the preparation of a 3-methyl-7-keto-8- (3'-ketobutyl) -3, 4- [3'-acyloxy-cyclo-pentano- (2 ', 1')] decahydronaphthalene compound

Info

Publication number
DE1195306B
DE1195306B DEL40409A DEL0040409A DE1195306B DE 1195306 B DE1195306 B DE 1195306B DE L40409 A DEL40409 A DE L40409A DE L0040409 A DEL0040409 A DE L0040409A DE 1195306 B DE1195306 B DE 1195306B
Authority
DE
Germany
Prior art keywords
ketobutyl
keto
methyl
acyloxy
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DEL40409A
Other languages
German (de)
Inventor
Dr-Ing Gerard Nomine
Dr Robert Bucourt
Andre Pierdet
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Roussel Uclaf SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf SA filed Critical Roussel Uclaf SA
Publication of DE1195306B publication Critical patent/DE1195306B/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/02Esters of acyclic saturated monocarboxylic acids having the carboxyl group bound to an acyclic carbon atom or to hydrogen
    • C07C69/22Esters of acyclic saturated monocarboxylic acids having the carboxyl group bound to an acyclic carbon atom or to hydrogen having three or more carbon atoms in the acid moiety
    • C07C69/24Esters of acyclic saturated monocarboxylic acids having the carboxyl group bound to an acyclic carbon atom or to hydrogen having three or more carbon atoms in the acid moiety esterified with monohydroxylic compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/385Saturated compounds containing a keto group being part of a ring
    • C07C49/487Saturated compounds containing a keto group being part of a ring containing hydroxy groups
    • C07C49/507Saturated compounds containing a keto group being part of a ring containing hydroxy groups polycyclic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Description

BUNDESREPUBLIK DEUTSCHLAND FEDERAL REPUBLIC OF GERMANY

DEUTSCHESGERMAN

PATENTAMTPATENT OFFICE

AUSLEGESCHRIFTEDITORIAL

Int. Cl.:Int. Cl .:

C07cC07c

Deutsche KL: 12 ο-25/04 German KL: 12 ο -25/04

Nummer: 1195 306Number: 1195 306

Aktenzeichen: L 40409IV b/12 οFile number: L 40409IV b / 12 ο

Anmeldetag: 7. November 1961Filing date: November 7, 1961

Auslegetag: 24. Juni 1965Opening day: June 24, 1965

Das Hauptpatent 1 142 603 betrifft ein Verfahren, welches darin besteht, daß man eine Zl8-3-Methyl-7-keto-8-(3"-ketobutyl)-3,4, - ß'-acyloxy-cyclopentano-(2',l')]-octahydronaphthalinverbindung der allgemeinen Formel IThe main patent 1 142 603 relates to a process which consists in the fact that a Zl 8 -3-methyl-7-keto-8- (3 "-ketobutyl) -3,4, - ß'-acyloxy-cyclopentano- (2nd ', l')] - octahydronaphthalene compound of the general formula I.

OAcOAc

worin Ac den Rest einer niederen aliphatischen oder einer aromatischen Carbonsäure bedeutet, katalytisch hydriert, wobei man die entsprechende 3-Methyl-7-keto-8-(3"-ketobutyl)-3,4-[3'-acyloxy-cyclopentanoso (2',r)]-decahydronaphthalinverbindung der Formelllwhere Ac is the residue of a lower aliphatic or an aromatic carboxylic acid, catalytic hydrogenated, the corresponding 3-methyl-7-keto-8- (3 "-ketobutyl) -3,4- [3'-acyloxy-cyclopentanoso (2 ', r)] - decahydronaphthalene compound of the formula

OAcOAc

erhält, die auch als Sß
4,5-seco-androstan bezeichnet werden kann. Gemäß Hauptpatent wird die letztere Verbindung anschließend mit Hilfe von Dehydratisierungsmitteln zu 19-nor-Testosteron cyclisiert.
receives, which is also called sweet
4,5-seco-androstane can be designated. According to the main patent, the latter compound is then cyclized to 19-nor-testosterone with the aid of dehydrating agents.

Nach dem Verfahren des genannten Hauptpatents, wird die katalytische Hydrierung der Doppelbindung in 8(9)-Stellung der Verbindung I auf herkömmliche Weise, d. h. in neutralem Milieu, durchgeführt, wobei ein farbloses Harz erhalten wird, das, wie nachträglich festgestellt worden ist, zum größten Teil aus einem Gemisch von etwa gleichen Mengen der beiden [9a, 10a H]- und [9ß, 100 H]-Isomeren des 3,5-Dioxo-17/9-acyloxy-19-nor-4,5-seco-androstans besteht, von denen lediglich das [9<x, 10« H]-Isomere durch Cyclisierung das 19-nor-Testosteron natürlicher Konfiguration liefert.According to the process of the cited main patent, the catalytic hydrogenation of the double bond in the 8 (9) position of the compound I is carried out in a conventional manner, that is to say in a neutral medium, a colorless resin being obtained which, as has subsequently been determined, for mostly from a mixture of approximately equal amounts of the two [9a, 10a H] and [9ß, 100 H] isomers of 3,5-dioxo-17/9-acyloxy-19-nor-4,5-seco- androstans, of which only the [9 <x, 10 «H] isomer provides the 19-nor-testosterone of natural configuration by cyclization.

Die vorliegende Erfindung betrifft eine Verbesserung der Hydrierungsstufe des Verfahrens des Hauptpatents die darin besteht, daß man die katalytische Hydrierung Verfahren zur Herstellung einer 3-Methyl-The present invention relates to an improvement in the hydrogenation stage of the process of the main patent which consists in the fact that the catalytic hydrogenation process for the preparation of a 3-methyl-

7-keto-8-(3"-ketobutyl)-3,4-[3'-acyloxy-cyclo-7-keto-8- (3 "-ketobutyl) -3,4- [3'-acyloxy-cyclo-

pentano-(2',l')]-decahydronaphthalmverbindungpentano (2 ', l')] decahydronaphthalm compound

Zusatz zum Patent: 1142 603Addendum to the patent: 1142 603

Anmelder:
Roussel-Uclaf, Paris
Applicant:
Roussel-Uclaf, Paris

Vertreter:Representative:

Dr. F. Zumstein,Dr. F. Zumstein,

Dipl.-Chem. Dr. rer. nat. E. AssmannDipl.-Chem. Dr. rer. nat. E. Assmann

und Dipl.-Chem. Dr. R. Koenigsberger,and Dipl.-Chem. Dr. R. Koenigsberger,

Patentanwälte, München 2, Bräuhausstr. 4Patent Attorneys, Munich 2, Bräuhausstr. 4th

Als Erfinder benannt:Named as inventor:

Dr.-Ing. Gerard Nomine, Noisy-le-Sec, Seine;
Dr. Robert Bucourt, Villiers-le-Bel, Seine-et-Oise; Andre Pierdet, Noisy-le-Sec, Seine (Frankreich)
Dr.-Ing. Gerard Nomine, Noisy-le-Sec, Seine;
Dr. Robert Bucourt, Villiers-le-Bel, Seine-et-Oise; Andre Pierdet, Noisy-le-Sec, Seine (France)

Beanspruchte Priorität:Claimed priority:

Frankreich vom 16. November 1960 (844101)France of November 16, 1960 (844101)

der Doppelbindung in 8(9)-Stellung der Verbindung I in einem basischen Milieu, insbesondere bei einem pH-Wert um 11, in Gegenwart eines Katalysators auf der Basis von Palladiumhydroxyd durchführt.the double bond in the 8 (9) position of the compound I in a basic medium, in particular in a pH around 11, in the presence of a catalyst based on palladium hydroxide.

Nach einer besonderen Ausführungsform des erfindungsgemäßen Verfahrens wird die Basizität des Reaktionsmilieus durch Zugabe von Triäthylamin bewirkt.According to a particular embodiment of the invention In the process, the basicity of the reaction medium is made by adding triethylamine causes.

Durch die erfindungsgemäße Abänderung des Verfahrens des Hauptpatents verläuft die Hydrierung stereospezifisch, und die Ausbeute an dem gewünschten [9a, 10a H]-Isomeren wird beträchtlich erhöht.As a result of the inventive modification of the process of the main patent, the hydrogenation takes place stereospecific, and the yield of the desired [9a, 10a H] isomer is increased considerably.

Das neue Verfahren ergibt unter Verwendung der Ausgangsverbindung I, worin Ac = C6H5CO bedeutet, eine Ausbeute von 95°/o an reinem 3,5-Dioxo-17/J-benzoyloxy-[9a,10a H]-19-nor-4,5-seco-androstan, das leicht kristallisierbar ist.The new process results in using the starting compound I in which Ac represents = C 6 H 5 CO, a yield of 95 ° / o of pure 3,5-dioxo-17 / J-benzoyloxy [9a, 10a H] -19- nor-4,5-seco-androstane, which is easy to crystallize.

509 597/427509 597/427

Das folgende Beispiel dient zur näheren Erläuterung des erfindungsgemäßen Verfahrens.The following example serves to explain the process according to the invention in more detail.

Beispielexample

Herstellung von 3-Methyl-7-keto-8-(3"-ketobutyl)-Production of 3-methyl-7-keto-8- (3 "-ketobutyl) -

3,4-[3'-benzoyloxy-cyclopentano-(2',r)]-decahydro-3,4- [3'-benzoyloxy-cyclopentano- (2 ', r)] - decahydro-

naphthalin (Verbindung II, Ac = C8H5CO)naphthalene (compound II, Ac = C 8 H 5 CO)

Man löst 550 mg J8-3-Methyl-7-keto-8-(3"-ketobutyl)-3,4-[3'-benzoyloxy-cyclopentano-(2', l')]-octahydronaphthalin (Verbindung I, Ac = C6H5CO) vom F. = 117°C, [«]£ = + 43° (c = 1 % Methanol), das, wie im Hauptpatent 1 142 603 beschrieben, erhalten wurde, in 40 ecm 950ZoIg6D1 Äthanol. Die Lösung wird zu einer Suspension von 40 mg Palladium-Kohle, die 15% Palladiumhydroxyd enthält, in 5 ecm Alkohol gefügt. Dann gibt man eine 10%ige alkoholische Triäthylaminlösung zu, bis der pH-Wert 11 erreicht ist; anschließend rührt man unter Wasserstoifatmosphäre IVs Stunden. Man filtriert, dampft das Filtrat im Vakuum zur Trockne ein und kristallisiert den Rückstand aus Isopropyläther. Ausbeute: 431 mg (etwa 78 %) an 3-Methyl-7-keto-8-(3"-ketobutyl)-3,4-[3'-benzoyloxy - cyclopentano - (2', I1)] - decahydronaphthalin vom augenblicklichen F. = 1140C. [«]!? = + 48° (c = 1 % Methanol). Aus der Mutterlauge kann man noch 17% des identischen Produktes gewinnen. Das Produkt ergibt sich in Form farbloser Nadeln, die in Methanol und Äthanol löslich und in Wasser und verdünnten wäßrigen Säuren und Alkalien unlöslich sind.550 mg of I 8 -3-methyl-7-keto-8- (3 "-ketobutyl) -3,4- [3'-benzoyloxy-cyclopentano- (2 ', l')] - octahydronaphthalene (compound I, Ac = C 6 H 5 CO), mp = 117 ° C, [ «] £ = + 43 ° (c = 1% methanol) which was obtained as described in the main Patent 1,142,603, in 40 cc of 95 0 ZoIg 6 D 1 Ethanol The solution is added to a suspension of 40 mg palladium-carbon, which contains 15% palladium hydroxide, in 5 cm alcohol.Then a 10% alcoholic triethylamine solution is added until the pH value 11 is reached The mixture is then stirred under a hydrogen atmosphere for IVs hours. It is filtered, the filtrate is evaporated to dryness in vacuo and the residue is crystallized from isopropyl ether. Yield: 431 mg (about 78%) of 3-methyl-7-keto-8- (3 " -ketobutyl) -3,4- [3'-benzoyloxy - cyclopentano - (2 ', I 1 )] - decahydronaphthalene of the current F. = 114 0 C. [«] !? = + 48 ° (c = 1% methanol). 17% of the identical product can still be obtained from the mother liquor. The product results in the form of colorless needles which are soluble in methanol and ethanol and insoluble in water and dilute aqueous acids and alkalis.

Analyse: Cg6H88O4 = 396,5
Berechnet ... C 75,72%, H 8,13 %;
gefunden ... C75,7%, H8,2%.
Analysis: Cg 6 H 88 O 4 = 396.5
Calculated ... C 75.72%, H 8.13%;
found ... C75.7%, H8.2%.

UV-Spektrum in Äthanol:UV spectrum in ethanol:

ληαχ. = 230 πιμ, s == 14 300,
Xg111x- = 273 ΐημ, β = 940,
haax. = 280 ηαμ, e = 765.
ληαχ. = 230 πιμ, s == 14 300,
Xg 111x- = 273 ΐημ, β = 940,
haax. = 280 ηαμ, e = 765.

Rotationsdispersion:Rotary dispersion:

[Ml400 = + 190[Ml 400 = +190

[M]317 = — 3480 (Minimum)[M] 317 = - 3480 (minimum)

[M]300=+ 290[M] 300 = + 290

[M]350=- 245[M] 350 = - 245

[M]309 = - 2650 (Inflexion)[M] 309 = - 2650 (inflexion)

[M]287 = 4880 (Spitze)[M] 287 = 4880 (peak)

Claims (2)

Patentansprüche:Patent claims: 1. Verfahren zur Herstellung einer 3-Methyl-7-keto-8-(3"-ketobutyl)-3,4-[3'-acyloxy - cyclopentano-(2',l')]-decahydronaphthalinverbindungdurch katalytische Hydrierung einer einen entsprechenden ii8-3-Methyl-7-keto-8-(3"-ketobutyl)-3,4-[3'-acyloxy-cyclopentano-(2',l')]-octahydronaphthalinverbindung nach Patent 1 142603, dadurch gekennzeichnet, daß man hier die 8(9)-ständige Doppelbindung der zl8-3-Methyl-7-keto-8-(3"-ketobutyl) - 3,4 - [3'- acyloxy-cyclopentano - (2', 1')] - octahydronaphthalinverbindung der allgemeinen Formel1. A process for the preparation of a 3-methyl-7-keto-8- (3 "-ketobutyl) -3,4- [3'-acyloxy-cyclopentano- (2 ', 1')] -decahydronaphthalene compound by catalytic hydrogenation of a corresponding one ii 8 -3-Methyl-7-keto-8- (3 "-ketobutyl) -3,4- [3'-acyloxy-cyclopentano- (2 ', l')] - octahydronaphthalene compound according to Patent 1,142603, characterized in that that here the 8 (9) double bond of the zl 8 -3-methyl-7-keto-8- (3 "-ketobutyl) - 3,4 - [3'-acyloxy-cyclopentano - (2 ', 1' )] - octahydronaphthalene compound of the general formula OAcOAc worin Ac den Rest einer niederen aliphatischen oder einer aromatischen Carbonsäure bedeutet, in basischem Milieu, insbesondere bei einem pH-Wert um 11, in Gegenwart eines Katalysators auf der Basis von Palladiumhydroxyd hydriert.wherein Ac is the residue of a lower aliphatic or an aromatic carboxylic acid, in basic medium, in particular at a pH value around 11, in the presence of a catalyst on the Hydrogenated based on palladium hydroxide. 2. Verfahren nach Anspruch 1, dadurch gekennzeichnet, daß der basische pH-Wert des Reaktionsmilieus mit Hilfe von Triäthylamin bewirkt wird. 2. The method according to claim 1, characterized in that the basic pH value of the Reaction medium is effected with the help of triethylamine. In Betracht gezogene Druckschriften:
Angewandte Chemie, Bd. 72 (1960), S. 728.
Considered publications:
Angewandte Chemie, Vol. 72 (1960), p. 728.
509 597/427 6.65 © Bundesdruckerei Berlin509 597/427 6.65 © Bundesdruckerei Berlin
DEL40409A 1960-11-16 1961-11-07 Process for the preparation of a 3-methyl-7-keto-8- (3'-ketobutyl) -3, 4- [3'-acyloxy-cyclo-pentano- (2 ', 1')] decahydronaphthalene compound Pending DE1195306B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1195306X 1960-11-16

Publications (1)

Publication Number Publication Date
DE1195306B true DE1195306B (en) 1965-06-24

Family

ID=9668628

Family Applications (1)

Application Number Title Priority Date Filing Date
DEL40409A Pending DE1195306B (en) 1960-11-16 1961-11-07 Process for the preparation of a 3-methyl-7-keto-8- (3'-ketobutyl) -3, 4- [3'-acyloxy-cyclo-pentano- (2 ', 1')] decahydronaphthalene compound

Country Status (1)

Country Link
DE (1) DE1195306B (en)

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
None *

Similar Documents

Publication Publication Date Title
DE1163850B (en) Process for the production of new, non-ionic, skin-friendly derivatives of capillary-active tertiary amines
DE2923949C2 (en) Process for the production of 1,4-butanediol by catalytic hydrogenation of 1,4-butynediol
DE1168892B (en) Method for purifying butyne- (2) -diol- (1, 4)
DE1793732B2 (en) PROCESS FOR THE MANUFACTURING OF 17 (ACYLOXY OR ALKOXY) -POLYUNESATIGATED GONANES OR 8-ISOGONAN DERIVATIVES
DE1227914B (en) Process for the preparation of 3- (1, 2-dithia-cyclopentyl) -5-pentanoic acid
DE1228254B (en) Process for the production of antibacterially active dihydrofusidic acid or salts
DE1195306B (en) Process for the preparation of a 3-methyl-7-keto-8- (3&#39;-ketobutyl) -3, 4- [3&#39;-acyloxy-cyclo-pentano- (2 &#39;, 1&#39;)] decahydronaphthalene compound
DE1221388B (en) Fragrance composition
DE1943440A1 (en) New prostaglandin derivatives
DE2652165A1 (en) PROCESS FOR THE PRODUCTION OF VINCAMIN AND EPI-VINCAMIN FROM (-) TABERSONINE
DE877613C (en) Process for the preparation of alkyl derivatives of ª‰-[2-oxynaphthyl-(6)]-propionic acid with ovarian hormone activity
DE2721766C2 (en)
DE520939C (en) Process for the preparation of allyl alcohol
DE2328605C2 (en) Process for the preparation of a mixture of diastereoisomers of zearalanol
AT144989B (en) Process for the preparation of hydrogenation products of the follicular hormone.
DE2111606A1 (en) Process for the preparation of a mixture of diastereoisomers from zearalanol
DE929969C (en) Process for the catalytic hydrogenation of organic compounds
DE1518281A1 (en) Process for the production of fragrances of the ambratype
DE900938C (en) Process for the preparation of 1- (o-oxyphenyl) -1-oxy-2-aralkylamino-propanes
AT226707B (en) Process for the preparation of new 11b-benzo- (a) -quinolizine derivatives
DE1002337C2 (en) Process for the preparation of hydrophenanthrylcarboxylic acids
DE733808C (en) Process for the production of hormone-active substances
DE931770C (en) Process for the preparation of 17-oxypregnen- (5) -ol- (3) -one- (20)
DE1158506B (en) Process for the production of new therapeutically effective 16-methylene steroid-3-enolethers of the pregnan series
DE1134986B (en) Process for the production of cyclic 16 alpha, 17 alpha acetals and ketals of the 6 alpha-methylpregnane series.